​

Intended Use 

​

COVID-19 RT-PCR PNA KIT is an in vitro diagnostic product with real-time reverse transcription (RT)-Polymerase chain reaction (PCR) assay intended for the qualitative detection of nucleic acid from the SARS-CoV-2 known as SARS-2019-nCoV, novel CoronaVirus in respiratory specimens.

 

​

It uses the revolutionary method called PNA (Peptide Nucleic Acid), a first of its kind and one of the only test that is FDA-EUA approved!

​

• PNA-focused tests allow for less prep work which increases speed and fewer chances of contamination.

• PNA mimics DNA does not go the DNA polymerase, instead of reports signals by hybridization and selective binding.

• It is Temperature and Chemically stable

• It has been acknowledged in the academic field to be a strong potential of diagnostics with Rt-PCR and better test than the TaqMan probe.

 

​

 

Key Highlights

 

• Run time: 1.3 hours per 96 samples

• Target Region: RdRP, N gene, HuPO gene

• Specificity/ Sensitivity: 100%

• Accuracy: 99.999%    

• False-positive rate: <0.1%

• LOD: 2.5 cp/µL

• Storage Temperature -10 to -30 °C

• stable for up to 1 year from the manufactured date

• 100 tests per box

• Compatible with your current PCR

• Integration and Procedure are seamless.

​​

​